{"count":3,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/12e1fca5-793d-4526-9450-80bea73b8142/","filing_uuid":"12e1fca5-793d-4526-9450-80bea73b8142","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/12e1fca5-793d-4526-9450-80bea73b8142/print/","filing_document_content_type":"text/html","income":null,"expenses":"280000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Laura Whitton","dt_posted":"2026-04-20T17:07:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1350 I STREET, NW, SUITE 250","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":20994,"url":"https://lda.gov/api/v1/registrants/20994/","house_registrant_id":31468,"name":"BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)","description":"Charitable funder of diabetes research","address_1":"1400 K STREET, NW, SUITE 1212","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA WHITTON","contact_telephone":"+1 202-465-4103","dt_updated":"2026-07-24T16:08:00.380613-04:00"},"client":{"id":127758,"url":"https://lda.gov/api/v1/clients/127758/","client_id":12,"name":"BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-10-07"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R.7148 - Consolidated Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":24850,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"WHITTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105961,"prefix":null,"prefix_display":null,"first_name":"PEDRO","nickname":null,"middle_name":null,"last_name":"MONTENEGRO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142486,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"INGRAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148491,"prefix":null,"prefix_display":null,"first_name":"DON","nickname":null,"middle_name":null,"last_name":"LYSTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":24850,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"WHITTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105961,"prefix":null,"prefix_display":null,"first_name":"PEDRO","nickname":null,"middle_name":null,"last_name":"MONTENEGRO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142486,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"INGRAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148491,"prefix":null,"prefix_display":null,"first_name":"DON","nickname":null,"middle_name":null,"last_name":"LYSTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c2b7c30f-b669-4075-8085-1508647994bc/","filing_uuid":"c2b7c30f-b669-4075-8085-1508647994bc","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c2b7c30f-b669-4075-8085-1508647994bc/print/","filing_document_content_type":"text/html","income":null,"expenses":"220000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Laura Whitton","dt_posted":"2026-07-20T15:28:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1350 I STREET, NW, SUITE 250","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":20994,"url":"https://lda.gov/api/v1/registrants/20994/","house_registrant_id":31468,"name":"BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)","description":"Charitable funder of diabetes research","address_1":"1400 K STREET, NW, SUITE 1212","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA WHITTON","contact_telephone":"+1 202-465-4103","dt_updated":"2026-07-24T16:08:00.380613-04:00"},"client":{"id":127758,"url":"https://lda.gov/api/v1/clients/127758/","client_id":12,"name":"BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-10-07"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":24850,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"WHITTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105961,"prefix":null,"prefix_display":null,"first_name":"PEDRO","nickname":null,"middle_name":null,"last_name":"MONTENEGRO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142486,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"INGRAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148491,"prefix":null,"prefix_display":null,"first_name":"DON","nickname":null,"middle_name":null,"last_name":"LYSTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":24850,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"WHITTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105961,"prefix":null,"prefix_display":null,"first_name":"PEDRO","nickname":null,"middle_name":null,"last_name":"MONTENEGRO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142486,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"INGRAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148491,"prefix":null,"prefix_display":null,"first_name":"DON","nickname":null,"middle_name":null,"last_name":"LYSTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3ef93c2d-a5af-454f-b249-e890d4e1eef9/","filing_uuid":"3ef93c2d-a5af-454f-b249-e890d4e1eef9","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/3ef93c2d-a5af-454f-b249-e890d4e1eef9/print/","filing_document_content_type":"text/html","income":null,"expenses":"150000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Laura Whitton","dt_posted":"2026-10-20T17:15:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1350 I STREET, NW, SUITE 250","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":20994,"url":"https://lda.gov/api/v1/registrants/20994/","house_registrant_id":31468,"name":"BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)","description":"Charitable funder of diabetes research","address_1":"1400 K STREET, NW, SUITE 1212","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA WHITTON","contact_telephone":"+1 202-465-4103","dt_updated":"2026-07-24T16:08:00.380613-04:00"},"client":{"id":127758,"url":"https://lda.gov/api/v1/clients/127758/","client_id":12,"name":"BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-10-07"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":24850,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"WHITTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105961,"prefix":null,"prefix_display":null,"first_name":"PEDRO","nickname":null,"middle_name":null,"last_name":"MONTENEGRO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142486,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"INGRAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148491,"prefix":null,"prefix_display":null,"first_name":"DON","nickname":null,"middle_name":null,"last_name":"LYSTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":24850,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"WHITTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105961,"prefix":null,"prefix_display":null,"first_name":"PEDRO","nickname":null,"middle_name":null,"last_name":"MONTENEGRO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142486,"prefix":null,"prefix_display":null,"first_name":"CHRISTINA","nickname":null,"middle_name":null,"last_name":"INGRAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148491,"prefix":null,"prefix_display":null,"first_name":"DON","nickname":null,"middle_name":null,"last_name":"LYSTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}